Clinical trial
Amifostine Followed by High Dose Chemotherapy in Treating Patients With…
NCT00003269 · Scripps Health, Other · Completed
Key facts
| NCT number | NCT00003269 |
|---|---|
| Title | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors |
| Official title | A Phase II, Open-Label, Trial Evaluating the Efficacy of Amifostine in Patients With Cancers Receiving Outpatient Dose-intensive Cyclophosphamide, Etoposide, and Cisplatin (DICEP) Chemotherapy |
| Lead sponsor | Scripps Health, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Lymphoma, Ovarian Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | sargramostim, amifostine trihydrate, cisplatin, cyclophosphamide, etoposide |
| Enrollment | 20 |
| Start date | Feb 1, 1998 |
| Primary completion | Jan 1, 2001 |
| Completion | Jan 1, 2001 |
| First posted | May 24, 2004 |
| Last update posted | Jan 10, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: